Мальта - англійська - Malta Medicines Authority

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - dinoprostone - vaginal gel - dinoprostone 2 mg - other gynecologicals

США - англійська - NLM (National Library of Medicine)

pharmacia and upjohn company llc - dinoprostone (unii: k7q1jqr04m) (dinoprostone - unii:k7q1jqr04m) - - prostin e2 vaginal suppository is indicated for the termination of pregnancy from the 12th through the 20th gestational week as calculated from the first day of the last normal menstrual period. - prostin e2 is also indicated for evacuation of the uterine contents in the management of missed abortion or intrauterine fetal death up to 28 weeks of gestational age as calculated from the first day of the last normal menstrual period. - prostin e2 is indicated in the management of nonmetastatic gestational trophoblastic disease (benign hydatidiform mole). - hypersensitivity to dinoprostone [see warnings and adverse reactions] - acute pelvic inflammatory disease - patients with active cardiac, pulmonary, renal, or hepatic disease

Ізраїль - англійська - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - dinoprostone - vaginal tablets - dinoprostone 3 mg - dinoprostone - induction of labour.

Кенія - англійська - Pharmacy and Poisons Board

dinoprostone - gel - each 2gm vaginal gel contains: dinoprostone 2 mg - dinoprostone

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dinoprost trometamol 6.71 mg/ml equivalent to to 5 mg/ml dinoprost - solution for injection - 5 mg/ml - active: dinoprost trometamol 6.71 mg/ml equivalent to to 5 mg/ml dinoprost - prostin f2 alpha sterile solution is indicated for term induction of labour and for evacuation of a third trimester foetal death in utero. prostin f2 alpha sterile solution is indicated for aborting a pregnancy between the 16th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period.

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - dinoprostone 10mg;   - pessary - 10 mg - active: dinoprostone 10mg   excipient: hydrogel texturised polyester yarn retrieval system - cervical ripening in patients, at or near term, who have favourable induction features and in whom there is a medical or obstetrical indication for induction of labour.

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dinoprostone 0.4 mg/ml - vaginal gel - 1mg/3g - active: dinoprostone 0.4 mg/ml excipient: colloidal silicon dioxide triacetin

Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - dinoprostone 0.8 mg/ml - vaginal gel - 2mg/3g - active: dinoprostone 0.8 mg/ml excipient: colloidal silicon dioxide triacetin - prostin e2 is indicated for the induction of labour in term or near term women who have favourable induction features; and who have singleton pregnancy with a vertex position.

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - dinoprostone - vaginal tablet - 3 milligram(s) - prostaglandins; dinoprostone

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - dinoprostone - concentrate for solution for infusion - 1 milligram(s)/millilitre - prostaglandins; dinoprostone